Molina Healthcare (NYSE:MOH) Director Sells $329,792.00 in Stock

Molina Healthcare, Inc (NYSE:MOH – Get Free Report) Director Dale Wolf sold 1,600 shares of the stock in a transaction on Friday, November 13th. The shares were sold at an average price of $206.12, for a total value of $329,792.00. Following the completion of the transaction, the director directly owned 14,337 shares in the company, valued at approximately $2,955,142.44. This represents a 10.04% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Molina Healthcare Trading Down 0.1%

NYSE MOH opened at $209.37 on Monday. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.95. The stock’s 50-day simple moving average is $202.56 and its two-hundred day simple moving average is $185.69. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $244.89. The company has a market capitalization of $10.93 billion, a price-to-earnings ratio of -218.09, a PEG ratio of 12.35 and a beta of 0.74.

Molina Healthcare (NYSE:MOH – Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.79 by $0.10. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The firm had revenue of $11.08 billion during the quarter, compared to analysts’ expectations of $10.86 billion. During the same period in the prior year, the business earned $1.84 EPS. The company’s revenue for the quarter was down 3.4% compared to the same quarter last year. Research analysts forecast that Molina Healthcare, Inc will post 5.30 EPS for the current fiscal year.

Analysts Set New Price Targets

MOH has been the subject of a number of recent research reports. JPMorgan Chase & Co. boosted their target price on Molina Healthcare from $220.00 to $225.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 27th. UBS Group upped their target price on Molina Healthcare from $202.00 to $225.00 and gave the stock a “neutral” rating in a research note on Friday, October 23rd. Zacks Research cut shares of Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 12th. Cantor Fitzgerald reissued a “neutral” rating on shares of Molina Healthcare in a research note on Friday, October 9th. Finally, Mizuho set a $255.00 price target on shares of Molina Healthcare in a research note on Friday, October 23rd. Three equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $213.88.

Get Our Latest Report on MOH

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Integrated Wealth Concepts LLC raised its holdings in Molina Healthcare by 56.9% during the 2nd quarter. Integrated Wealth Concepts LLC now owns 15,669 shares of the company’s stock valued at $3,584,000 after buying an additional 5,681 shares during the last quarter. Assenagon Asset Management S.A. boosted its position in Molina Healthcare by 394.1% during the 2nd quarter. Assenagon Asset Management S.A. now owns 156,632 shares of the company’s stock valued at $35,822,000 after buying an additional 124,929 shares during the period. Diamond Hill Capital Management LLC Investment Advisor purchased a new stake in Molina Healthcare during the 2nd quarter valued at $22,656,000. Summit Street Capital Management LLC bought a new stake in Molina Healthcare in the 2nd quarter worth $41,630,000. Finally, Pallas Capital Advisors LLC bought a new stake in Molina Healthcare in the 2nd quarter worth $2,229,000. 98.50% of the stock is owned by institutional investors.

Trending Headlines about Molina Healthcare

These are some of the MOH headlines that stood out recently:

  • Negative Sentiment: Zacks Research lowered its EPS estimates for Q1 2027 to $2.48 from $2.53, Q3 2027 to $2.17 from $2.23, and Q3 2028 to $3.85 from $4.06. The analyst firm maintained a Hold rating; the downward revisions may weigh on sentiment about Molina’s earnings outlook.
  • Negative Sentiment: Three insiders reported selling a combined 10,382 shares for about $2.11 million, reducing their individual holdings by roughly 6% to 12%. These sales may be viewed as a negative signal, though insider transactions alone do not establish a change in the company’s fundamentals. Jeff Barlow SEC filing Richard Schapiro SEC filing Dale Wolf SEC filing

About Molina Healthcare

(Get Free Report)

Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.

Recommended Stories

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.